FDA NDC Directory · JSON-LD · Markdown

TALTZ

NDC 0002-8905 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameixekizumab
Labeler / ManufacturerEli Lilly and Company
Marketing categoryBiologic License Application · App BLA125521
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsIXEKIZUMAB (40 mg/.5mL)
Marketing started20160322
Package count1

External sources

Source: openFDA. Public-domain (CC0).